Trials / Unknown
UnknownNCT05311098
Cryoablation With Vestibular Expansion for the Treatment of Paroxysmal/Short-course Persistent Atrial Fibrillation
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 400 (estimated)
- Sponsor
- Shanghai 10th People's Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study was to verify the safety and efficacy of routine and extended vestibular ablation in the treatment of paroxysmal/short-course persistent atrial fibrillation.
Detailed description
The purpose of this study was to verify the safety and efficacy of routine and extended vestibular ablation using the Medtronic Arctic Front AdvanceTM catheter in the treatment of paroxysmal/short-course persistent atrial fibrillation
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | cryoablation | Treatment of atrial fibrillation with cryoablation catheters |
Timeline
- Start date
- 2022-05-01
- Primary completion
- 2023-05-01
- Completion
- 2024-05-01
- First posted
- 2022-04-05
- Last updated
- 2022-05-26
Locations
1 site across 1 country: China
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05311098. Inclusion in this directory is not an endorsement.